Newsfeeds - Spark Newswire

3 minute read

34 Stocks Moving In Monday’s Mid-Day Session

Today, 5:34 PM

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.

ALNY

2 minute read

15 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 5:34 PM

Gainers IceCure Medical Ltd (NASDAQ: ICCM) rose 36.5% to $3.89 in pre-market trading. IceCure Medical, last week, received notice of intention to grant a European patent covering its cryogenic pump.

ARDS

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 5:34 PM

AVCO

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:34 PM

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday.

ACST

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 5:34 PM

Gainers BioCardia (NASDAQ:BCDA) shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCardia's trading volume reached 793.9K shares. This is 471.05% of its average volume over the last 100 days. The company's market cap stands at $49.0 million.

ADXS

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 5:34 PM

Gainers

BRTX

5 minute read

58 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:34 PM

Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.

ADBE

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 5:34 PM

Gainers

ARCT

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:34 PM

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.

ABM

2 minute read

Ensysce Biosciences Announces First Patients Enrolled In Phase 1 Study Of PF614-MPAR, Its Unique Technology Platform To Provide Opioid Overdose Protection

By Benzinga Newsdesk

Today, 5:34 PM

Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ:ENSC, OTC:ENSCW), a clinical-stage biotech company with novel technology platforms that may provide new hope for those in severe

ENSC